Pharma Q1 Results Preview: Shire, AbbVie, Bristol, Sanofi, Allergan

 
• By Scrip Team

All eyes are on Shire in its first quarter of reporting separate figures for its neuroscience division as Takeda ramps up the takeover pressure, while BMS, AbbVie, Sanofi, and Allergan primes pipeline for revenue growth.

Charts
• Source: Shutterstock

More from Earnings

More from Business